The procoagulant effect of Vitamin-K antagonists in patients with atrial fibrillation, atherosclerosis and deep venous thrombosis

被引：0
|
作者：
Al Dieri, R. [1 ]
ten Cate-Hoek, A. J. [2 ]
ten Cate, H. [2 ]
Hemker, H. C. [1 ]
机构：
[1] Maastricht Univ, Med Ctr, Cardiovasc Res Inst, Synapse Bv, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-683
引用
收藏
页码：857 / 857
页数：1
相关论文
共 50 条
  • [1] Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Wallentin, Lars
    Giugliano, Robert P.
    CIRCULATION, 2024, 149 (04) : 290 - 292
  • [2] Procoagulant effect of vitamin K antagonists?
    Al Dieri, R.
    Ten Cate-Hoek, A.
    Bloemen, S.
    Ten Cate, H.
    Hemker, H. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2511 - 2512
  • [3] Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis
    Locadia, M
    Sprangers, MAG
    de Haes, HCJM
    Büller, HR
    Prins, MH
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (01) : 101 - 107
  • [4] Polypharmacy and bleeding in atrial fibrillation: a real-world prospective cohort study on patients using vitamin-K antagonists
    Focks, J. Jaspers
    Albers-Akkers, M.
    Joustra, R.
    Bonnes, J.
    Van Vugt, S.
    Groos-Eekhoff, P.
    Bloem-De Vries, L.
    Verheugt, F.
    Brouwer, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1114 - 1115
  • [5] Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation
    Friberg, J
    Gislason, GH
    Gadsboll, N
    Rasmussen, JN
    Rasmussen, S
    Abildstrom, SZ
    Kober, L
    Madsen, M
    Torp-Pedersen, C
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (02) : 173 - 178
  • [6] Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
    Kozlowski, Dariusz
    Budrejko, Szymon
    Raczak, Grzegorz
    Rysz, Jacek
    Banach, Maciej
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (21) : 3816 - 3826
  • [7] Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials
    Verheugt, F. W. A.
    Jaspersfocks, J.
    Brouwer, M. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 672 - 672
  • [8] Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials
    Verheugt, F. W. A.
    Jaspersfocks, J.
    Brouwer, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 672 - 672
  • [9] INR Stability, Clinical Importance, and Predictors in Patients With Atrial Fibrillation and Venous Thromboembolism Receiving Vitamin K Antagonists
    White, C. Michael
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (06) : 253 - 259
  • [10] Decreased procoagulant phospholipids in patients with vitamin K antagonists
    Rousseau, A.
    Woodhams, B.
    Lenormand, B.
    Vasse, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 128 - 128
12345